http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2135169-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04975069e361e529398a0b025ad1c691
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b563b13d41982d189a7a40477f152d0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55e0128dfda198f3350cfc80df000e35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_722c3dc4573ddbf1e33148e995eef7e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c2f64e18c8b2b391c8221b6f3e14f2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9284466aec7d3c6d58c92d0d69d3e60e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
filingDate 1998-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1999-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c3b2e5988755e50306ce6332b1461c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b58ba5d4ac3b56056517d5bb1fb793de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fc8f32d070f107a8de761164a4b9ba5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48bc15aabeb01fe548105302badc866b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bdf6cf7afa0f1eed52f8fd10ccb6ac6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5752280dd77234439209147075ca511
publicationDate 1999-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2135169-C1
titleOfInvention Anti-inflammatory, analgetic, antipyretic drug and method of its preparing
abstract FIELD: pharmaceutical industry. SUBSTANCE: invention relates to drugs used in headache, neuralgia, toothache, cold and rheumatic diseases. An agent has caffeine, acetylsalicylic acid, paracetamol, starch, talc, calcium stearate, polyvinylpyrrolidone (molecular mass is 9900-35000 Da), cross-linked crospovidone and additionally - citric acid, cacao, lactose taken at the definite ratio of components. Also, invention proposes a method of preparing the proposed agent. EFFECT: increased strength of tablets, decreased time of their disintegration. 7 cl, 2 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010081722-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2455979-C2
priorityDate 1998-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448178750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3641

Total number of triples: 47.